Responses

Download PDFPDF
Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses [https://authors.bmj.com/after-submitting/rapid-responses/].
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses [https://www.bmj.com/company/journals-terms-and-conditions-for-rapid-responses/] and understand that your personal data will be processed in accordance with those terms and our privacy notice [https://www.bmj.com/company/your-privacy/].
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Response to Svasti-Salee, Snead and Alexander
    • Sebastian M. Waldstein, Retina Specialist Medical University of Vienna
    • Other Contributors:
      • Sophie Riedl, Registrar
      • Bianca S. Gerendas, Retina Specialist
      • Ursula Schmidt-Erfurth, Professor and Chair

    Dear Editor,

    We thank Svasti-Salee, Snead and Alexander [1] for their interest in our study and their comment regarding the reliability of spectral domain optical coherence tomography (SD-OCT) in differentiating a completely attached hyaloid versus complete posterior vitreous detachment (PVD).

    To address the author’s question, in our post-hoc analysis, only SD-OCT was used to diagnose PVD status. A slit-lamp examination specifically assessing for PVD was not performed per protocol in the TREND study, [2] therefore data other than SD-OCT were not available for post-hoc analysis.

    The accepted clinical methods to determine PVD include slit-lamp examination, dynamic ultrasonography and SD-OCT, while previous generations of OCT (time-domain OCT) potentially offered insufficient resolution and field of view. Of those methods, SD-OCT has the main advantage of being operator independent and allowing systematic, standardized evaluation in a reading center setting. The approach chosen for the analysis of the TREND dataset has been repeatedly performed in several prior studies, with similar outcome data. [3-5]

    A recent study cited by the authors [6] reports that PVD status on SD-OCT did not correlate well to intraoperative findings when patients underwent vitrectomy. However, vitrectomy surgery is performed in patients with vitreomacular interface disease, where often a multi-layered posterior vitreous cortex cleaving into separate planes is found, making...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Response to 'Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration
    • Carl R Svasti-Salee, Ophthalmologist Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
    • Other Contributors:
      • Martin P Snead, Vitreoretinal Surgeon
      • Philip Alexander, Vitreoretinal Surgeon

    Dear Editor,

    We read with interest the post-hoc study by Waldstein and colleagues concerning the impact of posterior vitreous detachment (PVD) on the efficacy of anti-VEGF treatment in neovascular age-related macular degeneration (AMD). However, the reliability of spectral-domain optical coherence tomography (SD-OCT) in confirming PVD status, upon which the findings of this study are dependent, is questionable.[1, 2] In particular, OCT is poor at distinguishing between fully attached vitreous and complete PVD.

    Hwang et al recently reported limited sensitivity of SD-OCT in detecting complete PVD when compared to clinical findings at the time of vitrectomy.[1] It was found that among patients awaiting vitrectomy, OCT diagnosis of complete PVD (based on the absence of visible posterior vitreous cortex or a premacular bursa on SD-OCT) had a positive predictive value of just 53% when compared to intra-operative findings.

    PVD remains a clinical diagnosis that is based on the identification of the posterior hyaloid membrane (PHM), a diaphanous, wrinkled film observable during biomicroscopic examination. The Weiss ring which it incorporates is a more variable and less reliable confirmatory sign of PHM detachment from the optic nerve head. The visible PHM is a consistent clinical finding in patients with PVD and correlates histopathologically with a type IV collagen basement membrane which begins life attached to the retina as the internal limiting membrane.[3...

    Show More
    Conflict of Interest:
    None declared.